FollowTheFilings

Managers Activity Compare Newest

Investment

ARRIVENT BIOPHARMA INC

Historical 13F holders

CUSIP: 04272N102
Type: Equity
Class: COM

Period	13F filings
2026 Q1	7
2025 Q4	7
2025 Q3	4
2025 Q2	4
2025 Q1	4
2024 Q4	3
2024 Q3	4

FollowTheFilings · Institutional 13F data room

All managers Activity Compare Newest filings X

Data is sourced from SEC EDGAR as filed. The SEC does not guarantee accuracy or completeness. Holdings exclude shorts and many derivatives; values are as of the report date.